Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5

Search this Article

Author(s)

    • TSUKAHARA Tomohide
    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine
    • KAWAGUCHI Satoshi
    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine
    • ASANUMA Hiroko
    • Division of Clinical Pathology, Sapporo Medical University Hospital
    • NAKAZAWA Emiri
    • Cancer Vaccine Laboratory, Innovation Plaza Hokkaido, Japan Science and Technology Agency
    • SHIMOZAWA Kumiko
    • Cancer Vaccine Laboratory, Innovation Plaza Hokkaido, Japan Science and Technology Agency
    • NABETA Yuki
    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine
    • KIMURA Shigeharu
    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine
    • KAYA Mitsunori
    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine
    • NAGOYA Satoshi
    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine
    • WADA Takuro
    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine
    • SATO Noriyuki
    • Department of Pathology, Sapporo Medical University School of Medicine

Journal

  • Cancer Sci

    Cancer Sci 97(12), 1374-1380, 2006-12-10

References:  42

Cited by:  5

Codes

  • NII Article ID (NAID)
    10020388005
  • NII NACSIS-CAT ID (NCID)
    AA11808050
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    13479032
  • Data Source
    CJP  CJPref 
Page Top